Effect of dietary energy restriction on vascular density during mammary carcinogenesis.
Inhibition of mammary carcinogenesis by dietary energy restriction is associated with a decrease in cell proliferation and the induction of apoptosis. Although changes in the metabolism of insulin-like growth factor I and glucocorticoids have been proposed to modulate these cellular processes, limitations in blood supply could induce similar effects. To investigate this possibility, female Sprague Dawley rats were given an injection of 1-methyl-1-nitrosourea and fed purified diets ad libitum or at 60% ad libitum intake, i.e., 40% dietary energy restriction. Premalignant mammary pathologies and mammary adenocarcinomas obtained from these rats were processed for vascular density analysis via CD-31 immunostaining. Vascular density, measured as vessels/unit area, of premalignant mammary pathologies and adenocarcinomas from dietary energy restriction rats was reduced 31 and 39%, respectively (P < 0.01). This effect, which was observed in a 50-microm wide band of tissue surrounding each pathology, was exerted on blood vessels > 25 microm2. Conversely, intratumoral vascular density was unaffected by dietary energy restriction. cDNA microarray and Western blot analyses of adenocarcinomas for evidence of dietary energy restriction-mediated effects on vascularization revealed that only the level of vascular endothelial growth factor receptor protein Flk-1 was significantly reduced (P < 0.001). It appears that dietary energy restriction imposes limitations in the supply of blood to developing pathologies, an effect that could directly inhibit the carcinogenic process. The vascular density data imply that dietary energy restriction inhibited the growth of endothelial cells but leave unresolved the question of whether dietary energy restriction had a specific effect on angiogenesis. The factors that account for the failure of dietary energy restriction to limit intratumoral vascularization are not obvious and merit additional investigation.
Cancer Prevention Laboratory, Colorado State University, Fort Collins, Colorado 80523, USA. henry.thompson@colostate.edu
Henry J
HJ
Thompson
John N
JN
McGinley
Nicole S
NS
Spoelstra
Weiqin
W
Jiang
Zongjian
Z
Zhu
Pamela
P
Wolfe
D000818:Animals; D015153:Blotting, Western; D031204:Caloric Restriction; D002273:Carcinogens; D002455:Cell Division / Q000502:physiology; D004730:Endothelium, Vascular / Q000166:cytology / Q000254:growth & development / Q000378:metabolism; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D008321:Mammary Glands, Animal / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D008325:Mammary Neoplasms, Experimental / Q000098:blood supply* / Q000139:chemically induced; D008770:Methylnitrosourea; D009389:Neovascularization, Pathologic / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D020411:Oligonucleotide Array Sequence Analysis; D011230:Precancerous Conditions / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D015431:Weight Loss / Q000502:physiology
D002273:Carcinogens; D042461:Vascular Endothelial Growth Factor A; D008770:Methylnitrosourea